Vedolizumab treatment persistence and safety in a 2‐year data analysis of an extended access programme.

Saved in:
Bibliographic Details
Title: Vedolizumab treatment persistence and safety in a 2‐year data analysis of an extended access programme.
Authors: Danese, Silvio1 (AUTHOR) sdanese@hotmail.com, Subramaniam, Kavitha2 (AUTHOR), Van Zyl, Jan3 (AUTHOR), Adsul, Shashi4 (AUTHOR), Lindner, Dirk4 (AUTHOR), Roth, Jeannine4 (AUTHOR), Vermeire, Séverine5 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Jan2021, Vol. 53 Issue 2, p265-272. 8p. 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.16160